Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer

ZHANG  Pin; WEN  Ling-zhu

doi:10.3969/j.issn.1671-5144.2012.03.015

ZHANG Pin, WEN Ling-zhu. Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2012.03.015

Citation:

ZHANG Pin, WEN Ling-zhu. Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2012.03.015

Citation:

ZHANG Pin, WEN Ling-zhu. Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2012.03.015

Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer

Catalog

Export File

Citation

Format

Content